In the world of venture capital (VC), every investment is a gamble.
At the time of investment, investors can’t know for certain whether a product will do well in the market. In some cases, they can’t even be sure a product is technologically feasible. Both risks are present for VC firms investing in biotechnology companies, where it’s common to invest in companies long before they have fully developed a product. READ MORE